Cistron Biotechnology(CIST)$.30 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve Harmon who wrote (1286)	7/20/1998 5:46:00 PM
From: scaram(o)uche	Read Replies (3) of 2742

Steve: I didn't think to ask. I am concerned with fundamental (science-based) business strategies and preventing Galton from making yet another mistake. It is my opinion that Galton is attempting to apply a 1985 business mind to 1998 biotech. Someone needs to take control, and it sounded, to me, like Naismith is intelligent and motivated. While we differed, he was sincere. I suggest that you call and ask. Zvi..... the reason for the ambiguity in the release is now clear. The letter of intent is subject to further definition. Or that's at least the impression that I was left with. Let's see if Brucie Baby has the brains to exclude cancer, while making certain that wording excludes Levy-like applications. Gotta be careful..... remember the GTI letter. If (1) the Connaught deal is restricted to infectious disease and does not include any "vector" or "naked DNA" applications, and (2) the royalty is decent, then I feel that it's a good deal. I won't list here what I consider to be a decent royalty, but I will post my thoughts after the deal is finalized. In any event, the royalty will not be disclosed. Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next